Physician profile
Amar Hamad
NPI 1598765166
$120,776.16
in general payments reported to CMS, 2019-2025
100 companies · $4,904 in 2025
The $4,904 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $13K · 2021: $27K · 2022: $29K · 2023: $17K · 2024: $14K · 2025: $4,904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Consulting Fee: $9,978 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,488 · Honoraria: $3,803 · Education: $561 · Long Term Medical Supply Or Device Loan: $167 · Travel and Lodging: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,651.04 |
| Consulting Fee | $9,978.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,488.00 |
| Honoraria | $3,803.00 |
| Education | $560.72 |
| Long Term Medical Supply Or Device Loan | $166.66 |
| Travel and Lodging | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $62,847.54 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Merck Sharp & Dohme LLC | $20,978.56 | 2019-2025 | Keytruda, Lynparza, Reblozyl |
| Astrazeneca Pharmaceuticals Lp | $9,782.80 | 2019-2025 | Lynparza, Calquence, Imfinzi |
| Global Blood Therapeutics, INC. | $4,341.43 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $2,490.87 | 2019-2025 | |
| Pfizer INC. | $1,454.84 | 2019-2025 | |
| Janssen Biotech, INC. | $1,449.55 | 2019-2025 | Darzalex, Erleada, Rybrevant |
| E.R. Squibb & Sons, L.L.C. | $1,245.75 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Genentech USA, INC. | $995.68 | 2019-2025 | Venclexta, Polivy, Tecentriq |
| Amgen INC. | $879.20 | 2019-2023 | Xgeva, Nplate, Vectibix |
| Lilly USA, LLC | $799.07 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Eisai INC. | $767.65 | 2019-2025 | |
| Abbvie INC. | $599.81 | 2019-2025 | |
| Glaxosmithkline, LLC. | $599.44 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Incyte Corporation | $561.21 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $554.37 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $540.94 | 2019-2025 | Ultomiris, Soliris |
| Regeneron Healthcare Solutions, INC. | $508.21 | 2019-2025 | Libtayo, Lynozyfic |
| Astellas Pharma US INC | $493.07 | 2019-2025 | Padcev, Xtandi, Vyloy |
| Celgene Corporation | $491.88 | 2019-2025 | Reblozyl, Pomalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $487.40 | 2019-2025 | Ninlaro, Fruzaqla, Iclusig |
| Daiichi Sankyo INC. | $453.49 | 2022-2025 | Injectafer, Enhertu, Datroway |
| Jazz Pharmaceuticals INC. | $381.84 | 2020-2025 | |
| Emd Serono, INC. | $374.14 | 2019-2024 | Tepmetko, Bavencio |
| Seagen INC. | $341.46 | 2019-2025 | Padcev, Tukysa |
| Pharmacyclics LLC, An Abbvie Company | $312.78 | 2019-2023 | Imbruvica |
| Gilead Sciences, INC. | $306.37 | 2021-2025 | Trodelvy |
| Exelixis INC. | $289.89 | 2019-2025 | Cabometyx |
| Karyopharm Therapeutics INC. | $278.14 | 2020-2025 | Xpovio |
| Array Biopharma INC | $276.86 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Bayer Healthcare Pharmaceuticals INC. | $212.67 | 2019-2025 | |
| Octapharma USA, INC. | $192.61 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Adc Therapeutics America, INC. | $186.89 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $176.29 | 2019-2025 | Onivyde |
| Kite Pharma, INC. | $175.12 | 2022-2025 | Yescarta |
| Sobi, INC | $174.33 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $172.73 | 2019-2022 | |
| Tersera Therapeutics LLC | $158.47 | 2023-2025 | Xermelo, Zoladex |
| G1 Therapeutics, INC. | $150.34 | 2022-2023 | Cosela |
| Pharmacosmos Therapeutics INC. | $134.87 | 2022-2024 | Cosela, Monoferric |
| Agios Pharmaceuticals, INC. | $122.75 | 2023-2025 | Pyrukynd |
| Ge Healthcare | $118.69 | 2021-2024 | |
| Beigene USA, INC. | $118.14 | 2020-2025 | Brukinsa |
| Stemline Therapeutics INC. | $115.02 | 2023-2025 | Orserdu |
| Blueprint Medicines Corporation | $103.85 | 2023-2025 | Ayvakit |
| Novo Nordisk INC | $103.10 | 2019-2023 | |
| Amneal Pharmaceuticals LLC | $102.02 | 2024-2025 | Alymsys, Avastin |
| Sanofi-Aventis U.S. LLC | $99.95 | 2021 | |
| Sumitomo Pharma America, INC. | $99.64 | 2023-2025 | Orgovyx |
| Ironwood Pharmaceuticals, INC | $97.45 | 2019 | |
| Servier Pharmaceuticals LLC | $95.01 | 2022-2024 | |
| Recordati_rare_diseases_inc. | $88.80 | 2023-2024 | Sylvant |
| Puma Biotechnology, INC. | $87.49 | 2019-2025 | |
| Deciphera Pharmaceuticals INC. | $85.80 | 2024-2025 | Qinlock, Romvimza |
| Myriad Genetic Laboratories, INC. | $80.76 | 2022 | |
| Immunocore Limited | $80.30 | 2024-2025 | Kimmtrak |
| Spectrum Pharmaceuticals INC. | $67.39 | 2023-2024 | Rolvedon |
| Blue Earth Diagnostics | $61.99 | 2021-2024 | |
| Tesaro, INC. | $61.42 | 2019 | |
| Taiho Oncology, INC. | $59.91 | 2019-2025 | |
| Morphosys, US INC. | $56.46 | 2021-2023 | Monjuvi |
| Tempus Ai, INC | $56.43 | 2024 | |
| Biocon Biologics INC | $54.56 | 2025 | Fulphila, Ogivri |
| Pharmaessentia USA Corporation | $53.37 | 2025 | Besremi |
| Tactile Systems Technology INC | $52.74 | 2025 | Flexitouch Plus, Nimbl |
| Iovance Biotherapeutics, INC. | $51.49 | 2025 | Amtagvi |
| Clovis Oncology, INC. | $48.24 | 2019-2021 | |
| Beone Medicines USA, INC. | $46.95 | 2025 | Brukinsa, Tevimbra |
| Coherus Oncology, INC. | $40.91 | 2022-2023 | |
| Verastem, INC. | $40.90 | 2019-2020 | |
| Immunogen, INC. | $38.34 | 2023-2024 | Elahere, Elahere |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.32 | 2019-2021 | |
| Dova Pharmaceuticals | $36.46 | 2020-2021 | |
| Myovant Sciences INC. | $36.07 | 2021 | |
| Aveo Pharmaceuticals, INC. | $35.88 | 2022-2024 | |
| Progenics Pharmaceuticals, INC. | $35.79 | 2022-2023 | Pylarify |
| Sun Pharmaceutical Industries INC. | $35.12 | 2019 | |
| Geron Corporation | $34.12 | 2025 | Rytelo |
| Springworks Therapeutics, INC. | $29.85 | 2025 | |
| Adaptive Biotechnologies Corporation | $28.09 | 2025 | Clonoseq |
| Caris Mpi, INC. | $26.50 | 2025 | Mi Cancer Seek |
| Syndax Pharmaceuticals, INC. | $25.90 | 2025 | |
| Macrogenics, INC. | $24.87 | 2022 | |
| Eusa Pharma (US) LLC | $23.88 | 2022 | |
| Shorla Oncology INC. | $23.84 | 2025 | |
| Legend Biotech USA INC. | $23.22 | 2025 | Carvykti |
| Alnylam Pharmaceuticals INC. | $22.89 | 2021 | |
| Amag Pharmaceuticals, INC. | $22.75 | 2019 | |
| Mauna Kea Technologies, INC. | $21.85 | 2021 | |
| Apellis Pharmaceuticals, INC. | $21.38 | 2024 | Empaveli |
| Mirati Therapeutics, INC. | $20.08 | 2023 | Krazati |
| Sirtex Medical INC | $19.85 | 2019 | |
| Accord Healthcare, INC. | $19.21 | 2025 | |
| Secura Bio, INC. | $16.39 | 2024 | Copiktra |
| Fortovia Therapeutics, INC. | $16.33 | 2020 | |
| Novocure INC. | $16.19 | 2025 | Optune Lua (Novottf-200t) |
| Lexicon Pharmaceuticals, INC. | $16.14 | 2020 | |
| Acrotech Biopharma INC. | $16.04 | 2021 | |
| Dendreon Pharmaceuticals LLC | $15.61 | 2019 | |
| Fennec Pharmaceuticals, INC. | $14.65 | 2024 | Pedmark |
Drugs and devices associated with these payments
Rezlidhia $16KTavalisse $16KKeytruda $638Lenvima $485Verzenio $471Lynparza $415Libtayo $386Opdivo $379Venclexta $376Padcev $375Kisqali $333Xtandi $274Enhertu $269Jaypirca $267Reblozyl $266Imbruvica $241Retevmo $235Zepzelca $233Darzalex $231Zejula $226Jemperli $226Braftovi $219Calquence $219Orgovyx $217Erleada $214Imfinzi $213Ultomiris $197Rybrevant $181Tukysa $178Elrexfio $174Adcetris $174Sarclisa $173Fabhalta $171Talzenna $168Lutathera $166Cosela $164Ninlaro $162Injectafer $158Epkinly $157Panzyga $155Mektovi $150Bosulif $142Ibrance $138Jakafi $135Trodelvy $135Elahere $128Talvey $126Lorbrena $126Yescarta $126Eliquis $125Xermelo $123Ayvakit $121Balversa $115Orserdu $115Scemblix $109Pyrukynd $107Brukinsa $107Fruzaqla $102Tecvayli $100Nubeqa $99.03Xofigo $99.03Ojjaara $93.97Soliris $93.95Onivyde $92.45Sylvant $88.80Xpovio $86.79Qinlock $85.80Emrelis $83.50Monjuvi $81.59Kimmtrak $80.30Bavencio $77.40Carvykti $72.71Tepmetko $71.09Cablivi $68.36Rolvedon $67.39Polivy $67.16Tibsovo $66.23Avastin $63.84Zynlonta $62.58Opdualag $61.59Vonjo $57.32Alymsys $56.21Tecentriq $55.00Pluvicto $54.50Datroway $53.98Vyloy $53.40Besremi $53.37Akeega $52.86Flexitouch Plus $52.74Nimbl $52.74Nplate $51.61Xgeva $51.61Amtagvi $51.49Cabometyx $49.30Enjaymo $48.06Itovebi $47.78Idhifa $45.72Inlyta $45.55Oxbryta $45.39Posluma $44.02
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Hamad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.